Judge throws book at Daniel Chapter One
This article was originally published in The Tan Sheet
Executive SummaryAn administrative judge upholds the Federal Trade Commission's charges that supplement marketer Daniel Chapter One falsely advertised its shark cartilage and herbal formulations prevent, treat and cure cancer. The judge found the firm could not substantiate its claims with reliable scientific evidence and ordered the company to stop making false claims. FTC charged Daniel Chapter One with deceptive advertising in 2008 in an enforcement sweep that charged 11 firms with marketing false cancer remedies (1"The Tan Sheet" Sept. 22, 2008)
You may also be interested in...
Keeping Track: US FDA's Rejection Of First RMAT BLA Blemishes Otherwise Positive Week Of Non-Oncology News
The latest non-oncology drug development news and highlights from our US FDA Performance Tracker.